#Transcatheter Mitral Valve Repair and Replacement Market

[univdatosmarket]

Transcatheter Mitral Valve Repair & Replacement Market was valued at US$ 5.24 million in 2020 and is anticipated to reach US$ 13.06 million by 2027 displaying an elevated CAGR of 11.25% over the forecast period (2021-2027)

[businessmarketreports]

Top Trends in the Heart Failure Major Market for 2024

Heart failure (HF) remains a significant global health concern, affecting millions and imposing a heavy burden on healthcare systems. However, the landscape of the heart failure market is undergoing a dynamic transformation, driven by innovation and a growing focus on improved patient outcomes.

Buy Full Report to Know More About the Heart Failure Market Forecast

Download a Free Report Sample

Here's a glimpse into the top trends shaping this market in 2024:

1. The Rise of Minimally Invasive Interventions:

Minimally Invasive Valve Replacement (MIVR): Traditional open-heart surgery for valve replacement is being challenged by MIVR procedures. These minimally invasive techniques offer faster recovery times, reduced patient discomfort, and potentially improved long-term outcomes.

Transcatheter Aortic Valve Replacement (TAVR): TAVR is a well-established MIVR option for aortic valve stenosis, particularly for high-risk patients who may not be suitable for open-heart surgery. Advancements in technology are enabling broader patient application of TAVR procedures.

Percutaneous Mitral Valve Repair (PMVR): PMVR is a newer technique gaining traction for mitral valve regurgitation. This minimally invasive approach offers a less invasive alternative to traditional mitral valve surgery.

2. Precision Medicine and Personalized Care:

Genetic Testing and Tailored Therapies: Identifying the underlying genetic causes of heart failure allows for more targeted treatment approaches. This could involve personalized medication regimens or therapies aimed at addressing specific genetic risk factors.

Remote Monitoring and Telehealth Solutions: Wearable devices and remote monitoring technologies allow for continuous patient monitoring, enabling early detection of potential complications and facilitating timely interventions. Telehealth consultations offer improved access to specialist care, particularly in remote areas.

3. The Growing Focus on Heart Failure Prevention:

Early Detection and Risk Management: Emphasis is shifting towards early detection of heart failure risk factors like hypertension, diabetes, and obesity. This allows for lifestyle modifications, medication management, and preventative measures to potentially delay or even prevent the onset of heart failure.

4. Innovation in Cardiac Devices and Technologies:

Next-Generation Ventricular Assist Devices (VADs): VADs are implanted pumps that assist the heart in pumping blood. Advancements in VAD technology are leading to smaller, more efficient, and quieter devices with improved long-term outcomes for patients.

Artificial Intelligence (AI) in Diagnostics and Treatment: AI algorithms are being used to analyze patient data, predict potential complications, and personalize treatment plans. AI-powered tools can also assist with early detection of heart failure based on medical scans or patient monitoring data.

5. Evolving Healthcare Delivery Models:

Focus on Value-Based Care: There's a growing emphasis on healthcare models that focus on patient outcomes and value delivered, rather than simply volume of procedures. This incentivizes the development of more effective and cost-efficient treatment strategies for heart failure.

The Rise of Cardiac Rehabilitation Programs: Comprehensive cardiac rehabilitation programs play a crucial role in improving patient outcomes and quality of life after a heart failure event. These programs combine exercise therapy, education, and psychological support to help patients manage their condition and live longer, healthier lives.

Conclusion:

The heart failure market is brimming with promising advancements. The focus on minimally invasive procedures, personalized care, preventative measures, and innovative technologies offers hope for improved patient outcomes and a brighter future for those living with heart failure. As these trends continue to evolve, the heart failure market will play a vital role in alleviating the burden of this global health challenge.

[fairfield-research]

Mitral Valve Disease Market Key Players, Size, Trends, Opportunities & Growth Analysis 2030

The global market for mitral valve disease is poised for substantial growth, with projections indicating a staggering increase from its current valuation of US$2.8 billion to a remarkable US$5.12 billion by the year 2030. This growth trajectory is underpinned by a robust compound annual growth rate (CAGR) of 9% expected between 2023 and 2030, according to a comprehensive report titled Mitral Valve Disease Market Snapshot, 2018-2030.

For More Industry Insight: https://www.fairfieldmarketresearch.com/report/mitral-valve-disease-market

Rising Prevalence and Technological Advancements Fuel Market Expansion

Mitral valve disease, a condition marked by abnormalities in the mitral valve structure, has witnessed an escalation in prevalence driven by factors such as congenital abnormalities, infections, and an ageing population. With an estimated 26 million individuals worldwide affected by mitral valve disease, the market is propelled by a growing need for advanced therapies to address the condition's symptoms.

Advancements in medical technology, including innovative pharmaceuticals and cutting-edge treatment modalities, have revolutionized the management of mitral valve disorders. Pioneering approaches such as the MitraClip and the Intrepid transcatheter mitral valve replacement (TMVR) system have significantly enhanced treatment efficacy, driving market growth through increased adoption of minimally invasive techniques.

Market Dynamics and Key Growth Determinants

Key factors driving the expansion of the mitral valve disease market include:

Growing Prevalence: With mitral valve disease affecting millions globally, its increasing prevalence, particularly among the elderly population, propels market growth.

Technological Advancements: Advancements in medical technology facilitate better management of mitral valve disorders, fostering market expansion through the adoption of cutting-edge treatment modalities.

Minimally Invasive Techniques: The rising demand for minimally invasive techniques for mitral valve treatment, coupled with the development of minimally invasive products, stimulates market growth.

Market Landscape and Regional Outlook

In 2022, the mitral valve repair segment dominated the market, attributed to its superior long-term outcomes and reduced risks compared to valve replacement. Additionally, North America held a significant market share, driven by its advanced healthcare infrastructure and increased consumer awareness of mitral valve disorders.

Competitive Landscape

The mitral valve disease market is characterized by intense competition, with several global players vying for market share. Leaders in the global mitral valve disease space include:

Abbott Laboratories

Medtronic plc

Edwards Lifesciences Corporation

Boston Scientific Corporation

LivaNova PLC

Micro Interventional Devices Inc.

XELTIS AG

Lepu Medical Technology (Beijing) Co. Ltd.

CryoLife Inc.

Colibri Heart Valve LLC

Valcare Medical

Affluent Medical

Teva Pharmaceutical Industries Ltd.

Pfizer Inc.

Bayer AG

[neha24blog]

Structural Heart Devices Market Segmented On The Basis Of Type, Region And Forecast 2028: Grand View Research Inc.

San Francisco, 22 Dec 2023: The Report Structural Heart Devices Market Size, Share & Trends Analysis Report By Type (Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Mitral Repair, Left Atrial Appendage Closure), By Region, And Segment Forecasts, 2023 – 2030 The global structural heart devices market size is expected to reach USD 12.8 billion by 2030, registering a CAGR…

[pranay-234]

Cardiac Valve Market: Trends, Analysis, and Industry Forecast 2023-2032

The global cardiac valve market is experiencing a transformative phase, marked by innovations, evolving trends, and a promising outlook for the future. This article delves into a comprehensive analysis of the cardiac valve market, offering insights into current dynamics, emerging trends, and forecasts that shape the landscape of this crucial segment in cardiovascular healthcare.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.alliedmarketresearch.com/request-toc-and-sample/11491

Market Dynamics: The cardiac valve market is driven by a confluence of factors, including the increasing prevalence of valvular heart diseases, advancements in medical technologies, and a growing aging population. Valvular heart diseases, such as aortic stenosis and mitral regurgitation, necessitate interventions like valve repair or replacement, propelling the demand for cardiac valves. Additionally, the rise in minimally invasive procedures and the pursuit of innovative valve technologies contribute to the dynamic growth observed in the market.

Precision in Valve Replacement: Artificial heart valves play a critical role in medical interventions by providing a precise and effective solution for replacing dysfunctional native heart valves. Positioned as one-way valves, these artificial counterparts are meticulously implanted to restore the essential function of maintaining unidirectional blood flow within the heart. By replicating the natural functionality of the tricuspid, pulmonic, mitral, or aortic valves, artificial heart valves alleviate the strain caused by valve malfunctions, offering patients a lifeline to improved cardiac health.

Mitigating Heart Valve Disorders: The human heart's four valves—tricuspid, pulmonic, mitral, and aortic—serve as gatekeepers, ensuring the seamless flow of blood in one direction. When these valves malfunction, impeding blood flow (stenosis) or allowing backward flow (regurgitation), it poses a significant threat to cardiovascular health. Artificial heart valves emerge as a crucial solution, mitigating the risks associated with valve disorders. By addressing issues such as stenosis and regurgitation, artificial heart valves contribute to preventing heart failure and fostering better cardiac outcomes for patients.

𝐏𝐫𝐞-𝐛𝐨𝐨𝐤 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 : https://www.alliedmarketresearch.com/cardiac-valve-market/purchase-options

Innovations in Cardiac Valve Technologies: Innovations in cardiac valve technologies are at the forefront of market trends. Transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR) are pioneering minimally invasive procedures that are gaining traction. These advancements not only offer alternatives to traditional surgical interventions but also present opportunities for improved patient outcomes, reduced recovery times, and enhanced accessibility to valve treatments.

Growing Significance of Bioprosthetic Valves: The market is witnessing a notable trend towards bioprosthetic valves, which are derived from animal tissues or are manufactured using synthetic materials. Bioprosthetic valves address concerns associated with long-term anticoagulation therapy, making them a preferred choice, especially for certain patient demographics. This shift towards bioprosthetic valves aligns with a patient-centric approach, emphasizing quality of life post-valve intervention.

Rising Demand for Aortic and Mitral Valve Interventions: Aortic and mitral valves play pivotal roles in cardiovascular function, and disorders affecting these valves are driving the demand for interventions. Aortic valve replacement procedures, including both surgical and transcatheter approaches, are witnessing increased adoption. Similarly, advancements in mitral valve repair and replacement techniques are addressing a spectrum of mitral valve pathologies, contributing to the overall growth of the cardiac valve market.

𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐭𝐨 𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐭𝐡𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭? 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 : https://www.alliedmarketresearch.com/purchase-enquiry/11491

Market Forecast and Growth Opportunities: The outlook for the cardiac valve market remains optimistic, with sustained growth anticipated in the coming years. As technology continues to evolve, opportunities for market expansion lie in refining existing interventions, exploring novel therapeutic approaches, and enhancing accessibility to cardiac valve treatments globally. The market is poised for strategic collaborations, technological partnerships, and research endeavors that will further propel its growth trajectory.

In conclusion, the global cardiac valve market stands at the intersection of innovation, patient-centric care, and advancing technologies. The coming years promise continued growth, driven by a commitment to addressing valvular heart diseases through cutting-edge interventions. As the market evolves, stakeholders, including manufacturers, healthcare providers, and researchers, play integral roles in shaping a future where cardiac valve treatments are not only effective but also increasingly accessible and tailored to the diverse needs of patients worldwide.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

[marketsizereports]

Key Players in the TAVR Market: A Comparative Analysis

The transcatheter Aortic Valve Replacement (TAVR) market has several key players who are at the forefront of developing and supplying TAVR devices. It's important to note that the landscape may evolve, and new players may emerge.

Here is a comparative analysis of some notable key players in the TAVR market:

1. Edwards Lifesciences Corporation:

Overview: A leading player in the TAVR market, Edwards Lifesciences is known for its SAPIEN and SAPIEN 3 transcatheter heart valves.

Strengths:

Extensive experience and a strong track record in the development of TAVR technology.

Continued innovation with a focus on enhancing valve designs and delivery systems.

2. Medtronic plc:

Overview: Medtronic is a global medical technology company that has a significant presence in the TAVR market with its CoreValve and Evolut R transcatheter valves.

Strengths:

Robust product portfolio with a range of TAVR solutions.

Ongoing commitment to research and development, leading to advancements in valve technology.

3. Boston Scientific Corporation:

Overview: Boston Scientific is actively involved in the TAVR market through its LOTUS Edge valve system.

Strengths:

Focus on addressing paravalvular leak issues with its repositionable and retrievable LOTUS valve.

Emphasis on delivering a comprehensive range of structural heart solutions.

4. Abbott Laboratories:

Overview: Abbott, through its Structural Heart division, offers the Portico transcatheter aortic valve system.

Strengths:

Differentiated technology with a self-expanding valve design.

Ongoing clinical trials and research to expand indications and improve outcomes.

5. JenaValve Technology, Inc.:

Overview: JenaValve is known for its JenaValve Pericardial TAVR system.

Strengths:

Unique design with a customizable, self-expanding valve.

Emphasis on patient-specific treatment approaches.

6. Meril Life Sciences Pvt. Ltd.:

Overview: An emerging player in the TAVR market, Meril offers the Myval transcatheter heart valve system.

Strengths:

Focus on affordability and accessibility, especially in emerging markets.

Continued expansion of its product portfolio.

7. Micro Interventional Devices, Inc.:

Overview: Micro Interventional Devices is known for its MIA Technology, including the MIA Transcatheter Annuloplasty Ring System.

Strengths:

Unique focus on annuloplasty solutions for mitral and tricuspid valve repair.

Commitment to addressing structural heart challenges beyond aortic valve replacement.

8. Braile Biomedica:

Overview: Braile Biomedica is a Brazilian company with a presence in the TAVR market through products like the Balloon-Expandable Braile Inovare Valve.

Strengths:

Contribution to the global TAVR market from a regionally based company.

Ongoing efforts in research and development.

9. LivaNova PLC:

Overview: LivaNova, through its Cardiac Surgery division, offers the Perceval Sutureless Aortic Heart Valve.

Strengths:

Sutureless valve design for simplified and faster implantation.

Broad cardiovascular portfolio addressing various cardiac conditions.

Comparative Considerations:

Innovation and Technology: Evaluate the level of innovation in valve design, delivery systems, and associated technologies.

Clinical Evidence: Consider the depth of clinical data and evidence supporting the safety and efficacy of each company's TAVR products.

Global Presence: Assess the global reach and market penetration of each company, including their efforts in both established and emerging markets.

Pipeline and R&D Commitment: Consider the companies' commitment to ongoing research and development, including potential pipeline products and advancements in TAVR technology.

It's crucial to note that the competitive landscape in the TAVR market is dynamic, and new players or developments may have emerged since my last update. Healthcare professionals and industry stakeholders should refer to the latest market reports and company announcements for the most current information.

[techninja]

A Lifeline for the Elderly: The Transcatheter Heart Valve Market's Role in Treating Heart Valve Diseases

The Transcatheter Heart Valve Market: Revolutionizing Cardiac Care

The Transcatheter Heart Valve Market has emerged as a revolutionary force in the field of cardiac care, offering innovative solutions for patients suffering from heart valve diseases. Unlike traditional open-heart surgeries, which can be invasive and carry significant risks, transcatheter heart valve procedures are minimally invasive and offer a less traumatic alternative. This market has witnessed substantial growth in recent years, driven by advancements in technology, an aging population, and a growing demand for less invasive cardiac interventions.

Heart valve diseases, such as aortic stenosis and mitral regurgitation, can significantly impact a person's quality of life and, if left untreated, lead to severe complications, including heart failure. Traditional surgical valve replacement or repair has been the standard of care for decades. However, not all patients are suitable candidates for open-heart surgery, either due to age, frailty, or other medical conditions. This is where transcatheter heart valve procedures step in, providing a lifeline for patients who might otherwise have limited options.

Transcatheter heart valve procedures involve the implantation of a prosthetic valve through minimally invasive techniques. The market comprises various types of transcatheter heart valves, including transcatheter aortic valves (TAVR) and transcatheter mitral valves (TMVR). The adoption of these procedures has been steadily rising due to their minimally invasive nature, shorter recovery times, and reduced risk of complications compared to open-heart surgery.

One key driver of the growth in the Transcatheter Heart Valve Market is the aging population. As people live longer, the prevalence of heart valve diseases increases. The elderly are more likely to develop heart valve conditions, and many of them are not ideal candidates for traditional surgery. Transcatheter heart valve procedures offer a ray of hope for this demographic, allowing them to receive life-saving treatment without the high risks associated with open-heart surgery.

Technological advancements have played a crucial role in the growth of the Transcatheter Heart Valve Market. Innovations in materials, design, and delivery systems have improved the safety and efficacy of transcatheter heart valve procedures. As a result, the success rates of these interventions have steadily increased, making them a viable option for a broader range of patients.

Furthermore, the healthcare industry's shift towards value-based care and cost containment has accelerated the adoption of transcatheter heart valve procedures. Minimally invasive techniques generally result in shorter hospital stays and quicker recovery times, reducing the overall cost of treatment and freeing up healthcare resources. As a result, both healthcare providers and patients are increasingly looking at transcatheter heart valve procedures as a cost-effective and efficient solution.

The Transcatheter Heart Valve Market is also marked by intense competition among medical device manufacturers. Leading companies invest heavily in research and development to create next-generation transcatheter heart valves that are more durable, easier to implant, and tailored to specific patient needs. This competitive landscape drives innovation and further expands the range of options available to healthcare providers and patients.

In conclusion, the Transcatheter Heart Valve Market is on a trajectory of growth and transformation. It offers a less invasive and more accessible option for patients suffering from heart valve diseases, especially the elderly and those with multiple comorbidities. As technology continues to advance and the market evolves, we can expect transcatheter heart valve procedures to become even more refined, cost-effective, and accessible, ultimately improving the quality of life for countless patients facing cardiac challenges. This market's promise lies in its potential to save lives and enhance the well-being of individuals while reshaping the landscape of cardiac care.

Few other promising reports in Medical Device Industry

3D Printing in Healthcare Market

Extracellular Matrix Market

Butterfly Needles Market

Colon Hydrotherapy Machine Market

[jesse-pinkman123]

Transcatheter Mitral Valve Repair and Replacement Market Trends Analysis-2027

Transcatheter Mitral Valve Repair and Replacement Market – Regional Analysis

On the basis of region, the Transcatheter Mitral Valve Repair and Replacement Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is projected to dominate transcatheter mitral valve repair and replacement market, owing to high prevalence of cardiac disease. For instance, in the U.S., heart disease is a leading cause of death, accounting for around 375,000 deaths annually. According to ClinicoEconomics and Outcomes Research 2016, Mitral regurgitation is the most frequent valve disease in the U.S. affecting nearly 1 in 10 people of 75 years or older.

Asia Pacific region is expected to witness significant growth, owing expansions of manufacturing facilities by market players. For instance, Medtronic, Inc. in March 2011, opened new manufacturing facility in Singapore to meet increasing demand for cardiac devices in region.

Transcatheter mitral valve repair and replacement methods are gaining significant traction due to advances in valve therapy. Transcatheter Mitral Valve Replacement (TMVR) can be used as an alternative to open-heart surgery and is used in treating mitral valve stenosis, mitral valve prolapse, and mitral valve regurgitation.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2189

Transcatheter Mitral Valve Repair and Replacement Market Drivers

Increasing mortality due to chronic and cardiovascular diseases especially in the elderly population is a major factor boosting the growth of the market. As per the American Heart Association estimates in 2017, around 19.1 million death occur annually worldwide due to various cardiovascular diseases. Furthermore, as per the United Nations (UN) estimates 2017, the geriatric population in the U.S. is expected to reach over 72 million by 2022. The growth of this target population coupled with increasing risk of cardiovascular diseases is expected to drive the growth of the market.

The global transcatheter mitral valve repair and replacement devices market is expected to witness growth, owing to continuous technological advancements such as developing multiple use valves. For instance, in June 2017, Edwards Lifesciences received FDA approval for its SAPIEN 3 transcatheter prosthetic heart valve, indicated for placement within both mitral valves and aortic valves.

Increase in number of TMVR pipeline devices for treatment of mitral valve abnormalities are also expected to propel growth of TMVR market. For instance, a randomized clinical trial of Medtronic Intrepid Transcatheter Mitral Valve Replacement System, sponsored by Medtronic Cardiovascular is ongoing for treating mitral valve regurgitation and is estimated to complete in October 2025.

Furthermore, in September 2018, Venus Medtech (Hangzhou) Inc., a China-based heart valve developer, acquired Israel-based medical device firm, Keystone Heart Ltd for Keystone’s TriGUARD 3 device, which is used to prevent cerebral embolism during Transcatheter mitral valve repair and replacement.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/transcatheter-mitral-valve-repair-and-replacement-market-2189

This acquisition provides an opportunity for Venus Medtech to expand their portfolio in other regions especially in the U.S. and Europe, Middle East, and Africa regions.

Transcatheter Mitral Valve Repair and Replacement Market Restraints

Stringent government regulations as well as high cost of mitral valve surgeries are major factors restraining growth of the market. For instance, according to an article published in National Chemical Biology Institute (NCBI), in September 2015, mean cost of TMVR surgery was US$ 42,806. According to Times of India March 2012, the cost of TMVR procedure in India was US$ 29,350 which include the estimated cost of valve US$ 21,500.

Transcatheter Mitral Valve Repair and Replacement Market – Competitive Analysis

The key players operating in the global transcatheter mitral valve repair and replacement devices market include Abbott Laboratories, Biotronik Private Limited, Colibri Heart Valve, Edward Lifesciences Corporation, HLT Medical, LivaNova Plc, Medtronic Plc, Neovasc Inc., and NeoChord.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2189

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

[martynnx-blog]

Transcatheter Mitral Valve Repair and Replacement Market 2018 Growth by Opportunities, Application, Driver, Current Trends and Forecast by 2026

Transcatheter mitral valve repair and replacement methods are gaining significant traction due to advances in valve therapy. Transcatheter Mitral Valve Replacement (TMVR) can be used as an alternative to open-heart surgery and is used in treating mitral valve stenosis, mitral valve prolapse, and mitral valve regurgitation.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2189

Transcatheter Mitral Valve Repair and Replacement Market Drivers

Increasing mortality due to chronic and cardiovascular diseases especially in the elderly population is a major factor boosting the growth of the market. As per the American Heart Association estimates in 2017, around 19.1 million death occur annually worldwide due to various cardiovascular diseases. Furthermore, as per the United Nations (UN) estimates 2017, the geriatric population in the U.S. is expected to reach over 72 million by 2022. The growth of this target population coupled with increasing risk of cardiovascular diseases is expected to drive the growth of the market.

The global transcatheter mitral valve repair and replacement devices market is expected to witness growth, owing to continuous technological advancements such as developing multiple use valves. For instance, in June 2017, Edwards Lifesciences received FDA approval for its SAPIEN 3 transcatheter prosthetic heart valve, indicated for placement within both mitral valves and aortic valves.

Transcatheter Mitral Valve Repair and Replacement Market – Regional Analysis

On the basis of region, the transcatheter mitral valve repair and replacement market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is projected to dominate transcatheter mitral valve repair and replacement market, owing to high prevalence of cardiac disease. For instance, in the U.S., heart disease is a leading cause of death, accounting for around 375,000 deaths annually. According to ClinicoEconomics and Outcomes Research 2016, Mitral regurgitation is the most frequent valve disease in the U.S. affecting nearly 1 in 10 people of 75 years or older.

Asia Pacific region is expected to witness significant growth, owing expansions of manufacturing facilities by market players. For instance, Medtronic, Inc. in March 2011, opened new manufacturing facility in Singapore to meet increasing demand for cardiac devices in region.

Transcatheter Mitral Valve Repair and Replacement Market – Competitive Analysis

The key players operating in the global transcatheter mitral valve repair and replacement devices market include Abbott Laboratories, Biotronik Private Limited, Colibri Heart Valve, Edward Lifesciences Corporation, HLT Medical, LivaNova Plc, Medtronic Plc, Neovasc Inc., and NeoChord.

[gurudige9987]

The global transcatheter mitral valve repair & replacement market was valued at $801.60 million in 2020, and is projected to reach $3.2 billion by 2030, growing at a CAGR of 14.8% from 2021 to 2030.

[en24news]

Repair and replacement of the transcatheter mitral valve Market growth industry and emerging trends 2018 - 2026

Repair and replacement of the transcatheter mitral valve Market growth industry and emerging trends 2018 – 2026

[ad_1]

The report on Repair and replacement of the transcatheter mitral valve 2018-2026 includes a complete analysis of the current market. The report begins with the basic overview of the Repair and Replacement of the Transcatheter Mitral Valve Industry, then goes into each detail.

Repair and Replacement of the Transcatheter Mitral Valve Market Report contains detailed…